{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:11:00Z","timestamp":1776082260393,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1479-5876-12-77","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T03:16:41Z","timestamp":1395458201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-\u03b1 antagonists"],"prefix":"10.1186","volume":"12","author":[{"given":"Valentina","family":"Germano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Sofia","family":"Cattaruzza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Di Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"D\u2019Amelio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,22]]},"reference":[{"key":"1773_CR1","first-page":"149","volume":"13","author":"R Myllykangas-Luosujarvi","year":"1995","unstructured":"Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Isomaki H: Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol. 1995, 13: 149-153.","journal-title":"Clin Exp Rheumatol"},{"key":"1773_CR2","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/art.22979","volume":"56","author":"A Gonzalez","year":"2007","unstructured":"Gonzalez A, Kremers MH, Crowson CS, Nicola PJ, Davis JM, Therneau TM, Roger VL, Gabriel SE: The widening mortality gap, between rheumatoid arthritis patients and the general population. Arthritis Rheum. 2007, 56: 3583-3587. 10.1002\/art.22979.","journal-title":"Arthritis Rheum"},{"key":"1773_CR3","first-page":"158","volume":"11","author":"JP Vanderbroucke","year":"1984","unstructured":"Vanderbroucke JP, Hazevoet HM, Cats A: Survival and cause of death in rheumatoid arthritis: a 25-year prospective follow-up. J Rheumatol. 1984, 11: 158-161.","journal-title":"J Rheumatol"},{"key":"1773_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.1780310513","volume":"31","author":"GA Van Albada-Kuipers","year":"1988","unstructured":"Van Albada-Kuipers GA, Linthorst J, Peeters EA, Breedveld FC, Dijkmans BA, Hermans J, Vandenbroucke JP, Cats A: Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism. Arthritis Rheum. 1988, 31: 667-671. 10.1002\/art.1780310513.","journal-title":"Arthritis Rheum"},{"key":"1773_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/art.1780140119","volume":"14","author":"J Baum","year":"1971","unstructured":"Baum J: Infection in rheumatoid arthritis. Arthritis Rheum. 1971, 14: 135-137. 10.1002\/art.1780140119.","journal-title":"Arthritis Rheum"},{"key":"1773_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/art.1780300711","volume":"30","author":"JP Vandenbroucke","year":"1987","unstructured":"Vandenbroucke JP, Kaaks R, Valkenburg HA, Boersma JW, Cats A, Festen JJ, Hartman AP, Huber-Bruning O, Rasker JJ, Weber J: Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis Rheum. 1987, 30: 810-813. 10.1002\/art.1780300711.","journal-title":"Arthritis Rheum"},{"key":"1773_CR7","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE: Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002, 46: 2287-2293. 10.1002\/art.10524.","journal-title":"Arthritis Rheum"},{"key":"1773_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/BOR.0b013e3282f4b392","volume":"20","author":"J Askling","year":"2008","unstructured":"Askling J, Dixon WG: The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis. Curr Opin Rheumatol. 2008, 20: 138-144. 10.1097\/BOR.0b013e3282f4b392.","journal-title":"Curr Opin Rheumatol"},{"key":"1773_CR9","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.23913","volume":"59","author":"D Lacaille","year":"2008","unstructured":"Lacaille D, Guh DP, Abrahamowicz M, Anis AH, Esdaile JM: Use of non biologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum (Arthritis Care Res). 2008, 59: 1074-1081. 10.1002\/art.23913.","journal-title":"Arthritis Rheum (Arthritis Care Res)"},{"key":"1773_CR10","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2011.1692","volume":"306","author":"CG Grijalva","year":"2011","unstructured":"Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR: Initiation of Tumor Necrosis Factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA. 2011, 306: 2331-2339.","journal-title":"JAMA"},{"key":"1773_CR11","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1136\/ard.2008.098822","volume":"69","author":"A Fouqu\u00e9-Aubert","year":"2010","unstructured":"Fouqu\u00e9-Aubert A, Jette-Paulin L, Combescure C, Basch A, Tebib J, Gossec L: Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials. Ann Rheum Dis. 2010, 69: 1756-1761. 10.1136\/ard.2008.098822.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.rdc.2012.08.019","volume":"38","author":"KL Winthrop","year":"2012","unstructured":"Winthrop KL: Infectious and biologic therapy in Rheumatoid Arthritis. Our changing understanding of risk and prevention. Rheum Dis Clin N Am. 2012, 38: 727-745. 10.1016\/j.rdc.2012.08.019.","journal-title":"Rheum Dis Clin N Am"},{"key":"1773_CR13","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"49","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE: Predictors of infection in Rheumatoid Arthritis. Arthritis Rheum. 2002, 49: 2294-2300.","journal-title":"Arthritis Rheum"},{"key":"1773_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/rheumatology\/kem076","volume":"46","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, Hudson M, Suissa S: Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford). 2007, 46: 1157-1160. 10.1093\/rheumatology\/kem076.","journal-title":"Rheumatology (Oxford)"},{"key":"1773_CR15","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN: Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000, 343: 1594-1602. 10.1056\/NEJM200011303432202.","journal-title":"N Engl J Med"},{"key":"1773_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","volume":"363","author":"L Kareskog","year":"2004","unstructured":"Kareskog L, van der Heijde D, De Jager JP, Gough A, Kalden J, Malaise M, Mart\u00edn Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M: TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet. 2004, 363: 675-681. 10.1016\/S0140-6736(04)15640-7.","journal-title":"Lancet"},{"key":"1773_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/ard.2005.044404","volume":"65","author":"ME Weinblatt","year":"2005","unstructured":"Weinblatt ME, Keystone EC, Furst DE, Kavanaugh AF, Chartash EK, Segurado OG: Long-term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4-year extended study. Ann Rheum Dis. 2005, 65: 753-759.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR18","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V: Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006, 295: 2275-2285. 10.1001\/jama.295.19.2275.","journal-title":"JAMA"},{"key":"1773_CR19","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M: Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy. Results From the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2006, 54: 2368-2376. 10.1002\/art.21978.","journal-title":"Arthritis Rheum"},{"key":"1773_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","volume":"39","author":"DE Furst","year":"2010","unstructured":"Furst DE: The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum. 2010, 39: 327-346. 10.1016\/j.semarthrit.2008.10.002.","journal-title":"Semin Arthritis Rheum"},{"key":"1773_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism. Association 1987 Revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"1773_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V: Psoriatic arthritis. Semin Arthritis Rheum. 1973, 3: 55-78. 10.1016\/0049-0172(73)90035-8.","journal-title":"Semin Arthritis Rheum"},{"key":"1773_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/rheumatology\/24.3.242","volume":"24","author":"HS Goie The","year":"1985","unstructured":"Goie The HS, Steven MM, van der Linden SM, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol. 1985, 24: 242-249. 10.1093\/rheumatology\/24.3.242.","journal-title":"Br J Rheumatol"},{"key":"1773_CR24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"British Thoracic Society Standards of care Committee","year":"2005","unstructured":"British Thoracic Society Standards of care Committee: BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF- \u03b1 treatment. Thorax. 2005, 60: 800-805.","journal-title":"Thorax"},{"key":"1773_CR25","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/art.22768","volume":"57","author":"JJ G\u00f3mez-Reino","year":"2007","unstructured":"G\u00f3mez-Reino JJ, Carmona L, Descalzo AM, Biobadaser Group: Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum. 2007, 57: 756-761. 10.1002\/art.22768.","journal-title":"Arthritis Rheum"},{"key":"1773_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.dld.2006.12.017","volume":"39","author":"A Marzano","year":"2007","unstructured":"Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Di Marco V, Fabrizi F, Fagiuoli S, Grossi P, Lampertico P, Meliconi R, Mangia A, Puoti M, Raimondo G, Smedile A, For the Italian Association for the Study of Liver (AISF): Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis. 2007, 39: 397-408. 10.1016\/j.dld.2006.12.017.","journal-title":"Dig Liver Dis"},{"key":"1773_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1517\/14712598.2012.646986","volume":"12","author":"M Vigan\u00f2","year":"2012","unstructured":"Vigan\u00f2 M, Degasperi E, Aghemo A, Lampertico P, Colombo M: Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management. Expert Opin Biol Ther. 2012, 12: 193-207. 10.1517\/14712598.2012.646986.","journal-title":"Expert Opin Biol Ther"},{"key":"1773_CR28","first-page":"1944","volume":"35","author":"C Ferri","year":"2008","unstructured":"Ferri C, Ferraccioli G, Ferrari D, Galeazzi M, Lapadula G, Montecucco C, Triolo G, Valentini G, Valesini. GISEA Group: Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. J Rheumatol. 2008, 35: 1944-1949.","journal-title":"J Rheumatol"},{"key":"1773_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jmv.20086","volume":"73","author":"F Pregliasco","year":"2004","unstructured":"Pregliasco F, Puzelli S, Mensi C, Anselmi G, Marinello R, Tanzi ML, Affinito C, Zambon MC, Donatelli I, The Collaborative Group Influchild: Influenza virological surveillance in children: the use of the Quickvue rapid diagnostic test. J Med Virol. 2004, 73: 269-273. 10.1002\/jmv.20086.","journal-title":"J Med Virol"},{"key":"1773_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/ard.2010.128637","volume":"70","author":"K Au","year":"2011","unstructured":"Au K, Reed G, Curtis JR, Kremer JM, Greenberg JD, Strand V, Furst DE, CORRONA investigators: High disease activity is associated with an increased risk of infection in patient with rheumatoid arthritis. Ann Rheum Dis. 2011, 70: 785-791. 10.1136\/ard.2010.128637.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/rheumatology\/kel236","volume":"46","author":"C Salliot","year":"2007","unstructured":"Salliot C, Gossec L, Ruyssen-Witrand A, Luc M, Duclos M, Guignard S, Dougados M: Infections during tumor necrosis factor-\u03b1-blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients. Rheumatology (Oxford). 2007, 46: 327-334.","journal-title":"Rheumatology (Oxford)"},{"key":"1773_CR32","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J, Strangfeld A, Kary S, Rau R, Von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A: Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum. 2005, 52: 3403-3412. 10.1002\/art.21386.","journal-title":"Arthritis Rheum"},{"key":"1773_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.autrev.2008.11.002","volume":"8","author":"EG Favalli","year":"2009","unstructured":"Favalli EG, Desiati F, Atzeni F, Sarzi-Puttini P, Caporali R, Pallavicini FB, Gorla R, Filippini M, Marchesoni A: Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients. Autoimmun Rev. 2009, 8: 266-273. 10.1016\/j.autrev.2008.11.002.","journal-title":"Autoimmun Rev"},{"key":"1773_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1056\/NEJM199901283400401","volume":"340","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ: A trial of Etanercept, a recombinant Tumor necrosis Factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999, 340: 253-259. 10.1056\/NEJM199901283400401.","journal-title":"N Engl J Med"},{"key":"1773_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/annrheumdis-2011-201108","volume":"72","author":"JB Galloway","year":"2013","unstructured":"Galloway JB, Mercer LK, Moseley A, Dixon WG, Ustianowski AP, Helbert M, Watson KD, Lunt M, Hyrich KL, Symmons DP: Risk of skin and soft tissue infections(including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2013, 72: 229-234. 10.1136\/annrheumdis-2011-201108.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2133.1995.tb08666.x","volume":"132","author":"RW Groves","year":"1995","unstructured":"Groves RW, Allen MH, Ross EL, Barker JN, MacDonald DM: Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol. 1995, 132: 345-352. 10.1111\/j.1365-2133.1995.tb08666.x.","journal-title":"Br J Dermatol"},{"key":"1773_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cyto.2004.09.008","volume":"29","author":"C Vestergaard","year":"2005","unstructured":"Vestergaard C, Johansen C, Otkjaer K, Deleuran M, Iversen L: Tumor necrosis factor induced CTACK\/CCL27 (cutaneous T cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappa B. Cytokine. 2005, 29: 49-55. 10.1016\/j.cyto.2004.09.008.","journal-title":"Cytokine"},{"key":"1773_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cyto.2005.07.011","volume":"32","author":"CE Griffiths","year":"2005","unstructured":"Griffiths CE, Dearman RJ, Cumberbatch M, Kimber I: Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine. 2005, 32: 67-70. 10.1016\/j.cyto.2005.07.011.","journal-title":"Cytokine"},{"key":"1773_CR39","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM: Tuberculosis associated with infliximab, a tumor necrosis factor-neutralizing agent. N Engl J Med. 2001, 345: 1098-1104. 10.1056\/NEJMoa011110.","journal-title":"N Engl J Med"},{"key":"1773_CR40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/acr.20130","volume":"62","author":"R Caporali","year":"2010","unstructured":"Caporali R, Bobbio-Pallavicini F, Atzeni F, Sakellariou G, Caprioli M, Montecucco C, Sarzi-Puttini P: Safety of Tumor Necrosis Factor Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative\/Anti\u2013Hepatitis B Core Antigen Positive) With Rheumatic Diseases. Arthritis Care Res. 2010, 62: 749-754. 10.1002\/acr.20130.","journal-title":"Arthritis Care Res"},{"key":"1773_CR41","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/rheumatology\/ker190","volume":"50","author":"AMG Brunasso","year":"2011","unstructured":"Brunasso AMG, Puntoni M, Gulia A, Massone C: Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review. Rheumatology. 2011, 50: 1700-1711. 10.1093\/rheumatology\/ker190.","journal-title":"Rheumatology"},{"key":"1773_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP, BSRBR Control Centre Consortium; British Society for Rheumatology Biologics Register: Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford). 2011, 50: 124-131. 10.1093\/rheumatology\/keq242.","journal-title":"Rheumatology (Oxford)"},{"key":"1773_CR43","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/ard.2006.062760","volume":"66","author":"J Askling","year":"2007","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, C\u00f6ster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantap\u00e4\u00e4-Dahlqvist S, Saxne T, Van Vollenhoven RF, Klareskog L: Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis. 2007, 66: 1339-1344. 10.1136\/ard.2006.062760.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR44","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","volume":"366","author":"TM Hooton","year":"2012","unstructured":"Hooton TM: Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012, 366: 1028-1037. 10.1056\/NEJMcp1104429.","journal-title":"N Engl J Med"},{"key":"1773_CR45","first-page":"1832","volume":"34","author":"P Coyne","year":"2007","unstructured":"Coyne P, Hamilton J, Haycock C, Saravanan V, Coulson E, Kelly CA: Acute lower respiratory tract infections in patients with rheumatoid arthritis. J Rheumatol. 2007, 34: 1832-1836.","journal-title":"J Rheumatol"},{"key":"1773_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","volume":"53","author":"J Listing","year":"2013","unstructured":"Listing J, Gerhold K, Zink A: The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology. 2013, 53: 53-61.","journal-title":"Rheumatology"},{"key":"1773_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.semcancer.2012.02.008","volume":"22","author":"J Kanterman","year":"2012","unstructured":"Kanterman J, Sade-Feldman M, Baniyash M: New insights into chronic inflammation-induced immunosuppression. Semin Cancer Biol. 2012, 22: 307-318. 10.1016\/j.semcancer.2012.02.008.","journal-title":"Semin Cancer Biol"},{"key":"1773_CR48","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1136\/ard.2010.144741","volume":"70","author":"WG Dixon","year":"2011","unstructured":"Dixon WG, Kezouh A, Bernatsky S, Suissa S: The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case\u2013control study. Ann Rheum Dis. 2011, 70: 956-960. 10.1136\/ard.2010.144741.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR49","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jaad.2010.09.734","volume":"64","author":"ED Dommasch","year":"2011","unstructured":"Dommasch ED, Abuabara K, Shin DB, Nguyen J, Troxel AB, Gelfand JM: The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. Am Acad Dermatol. 2011, 64: 1035-1050. 10.1016\/j.jaad.2010.09.734.","journal-title":"Am Acad Dermatol"},{"key":"1773_CR50","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/art.22600","volume":"56","author":"S Schneeweiss","year":"2007","unstructured":"Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH: Anti-tumour necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007, 56: 1754-1764. 10.1002\/art.22600.","journal-title":"Arthritis Rheum"},{"key":"1773_CR51","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/art.21568","volume":"54","author":"F Wolfe","year":"2006","unstructured":"Wolfe F, Caplan L, Michaud K: Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum. 2006, 54: 628-634. 10.1002\/art.21568.","journal-title":"Arthritis Rheum"},{"key":"1773_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.autrev.2012.06.008","volume":"12","author":"F Atzeni","year":"2012","unstructured":"Atzeni F, Sarzi-Puttini P, Botsios C, Carletto A, Cipriani P, Favalli EG, Frati E, Foschi V, Gasparini S, Giardina A, Gremese E, Iannone F, Sebastiani M, Ziglioli T, Biasi D, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Gorla R, Govoni M, Lapadula G, Marchesoni A, Salaffi F, Punzi L, Triolo G, Ferraccioli G: Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmun Rev. 2012, 12: 225-229. 10.1016\/j.autrev.2012.06.008.","journal-title":"Autoimmun Rev"},{"key":"1773_CR53","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1136\/ard.2011.151043","volume":"70","author":"A Strangfeld","year":"2011","unstructured":"Strangfeld A, Eveslage M, Schneider M, Bergerhausen HJ, Klopsch T, Zink A, Listing J: Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?. Ann Rheum Dis. 2011, 70: 1914-1920. 10.1136\/ard.2011.151043.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/7594","volume":"6","author":"BD Guenther","year":"1999","unstructured":"Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML: The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol. 1999, 6: 359-365. 10.1038\/7594.","journal-title":"Nat Struct Biol"},{"key":"1773_CR55","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jhep.2007.11.017","volume":"48","author":"JP Bronowicki","year":"2008","unstructured":"Bronowicki JP, Abdelmouttaleb I, Peyrin-Biroulet L, Venard V, Khiri H, Chabi N, Amouzou EK, Barraud H, Halfon P, Sanni A, Bigard MA, Le Faou A, Gu\u00e9ant JL: Methylenetetrahydrofolate reductase 677\u00a0T allele protects against persistent HBV infection in West Africa. J Hepatol. 2008, 48: 532-539. 10.1016\/j.jhep.2007.11.017.","journal-title":"J Hepatol"},{"key":"1773_CR56","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/gene.2009.50","volume":"10","author":"N Fodil-Cornu","year":"2009","unstructured":"Fodil-Cornu N, Kozij N, Wu Q, Rozen R, Vidal SM: Methylenetetrahydrofolate reductase (MTHFR) deficiency enhances resistance against cytomegalovirus infection. Genes Immun. 2009, 10: 662-666. 10.1038\/gene.2009.50.","journal-title":"Genes Immun"},{"key":"1773_CR57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2249.1996.tb08306.x","volume":"103","author":"L Lanza","year":"1996","unstructured":"Lanza L, Scudeletti M, Puppo F, Bosco O, Peirano L, Filaci G, Fecarotta E, Vidali G, Indiveri F: Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol. 1996, 103: 482-490.","journal-title":"Clin Exp Immunol"},{"key":"1773_CR58","first-page":"2182","volume":"82","author":"R DeRijk","year":"1997","unstructured":"DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Paciotti G, Gold PW, Sternberg EM: Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1b (IL-1b), IL-6, and Tumor Necrosis Factor-a (TNF\u03b1) Production in Humans: High Sensitivity of TNF\u03b1 and Resistance of IL-6. J Clin Endocrinol Metab. 1997, 82: 2182-2191.","journal-title":"J Clin Endocrinol Metab"},{"key":"1773_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2217\/ijr.12.8","volume":"7","author":"S Salemi","year":"2012","unstructured":"Salemi S, Germano V, Picchianti Diamanti A, D\u2019Amelio R: Role of antibody-secreting cells as early biomarkers of immune response to influenza vaccination in Rheumatoid arthritis patients treated with anti-TNF\u03b1 agents. Int J Clin Rheumatol. 2012, 7: 155-158. 10.2217\/ijr.12.8.","journal-title":"Int J Clin Rheumatol"},{"key":"1773_CR60","first-page":"425","volume-title":"Handbook of Physiology. Section 7: The Endocrine System. New York, Oxford University Press, 2001, vol 4: Coping with the Environment: Neural and Endocrine Mechanisms","author":"AH Miller","year":"2001","unstructured":"Miller AH, Pearce BD, Ruzek MC, Biron CA: Interactions between the hypothalamic-pituitary-adrenal axis and immune system during viral infection: pathways for environmental effects on disease expression. Handbook of Physiology. Section 7: The Endocrine System. New York, Oxford University Press, 2001, vol 4: Coping with the Environment: Neural and Endocrine Mechanisms. Edited by: McEwen BS. 2001, 425-450."},{"key":"1773_CR61","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJMra1009433","volume":"367","author":"EW Gelfand","year":"2012","unstructured":"Gelfand EW: Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases. N Engl J Med. 2012, 367: 2015-2025. 10.1056\/NEJMra1009433.","journal-title":"N Engl J Med"},{"key":"1773_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","volume":"9","author":"KM Kunisaki","year":"2009","unstructured":"Kunisaki KM, Janoff EN: Influenza in Immunosuppressed Populations: A Review of Infection Frequency, Morbidity, Mortality, and Vaccine Responses. Lancet Infect Dis. 2009, 9: 493-504. 10.1016\/S1473-3099(09)70175-6.","journal-title":"Lancet Infect Dis"},{"key":"1773_CR63","doi-asserted-by":"publisher","first-page":"e29249","DOI":"10.1371\/journal.pone.0029249","volume":"6","author":"CR Beck","year":"2011","unstructured":"Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, Orton E, B\u00e9chard-Evans L, Morgan G, Stevenson C, Weston R, Mukaigawara M, Enstone J, Augustine G, Butt M, Kim S, Puleston R, Dabke G, Howard R, O\u2019Boyle J, O\u2019Brien M, Ahyow L, Denness H, Farmer S, Figureroa J, Fisher P, Greaves F, Haroon M, Haroon S, Hird C: Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One. 2011, 6: e29249-10.1371\/journal.pone.0029249.","journal-title":"PLoS One"},{"key":"1773_CR64","first-page":"295","volume":"42","author":"JB Miller","year":"1979","unstructured":"Miller JB: Treatment of active herpes virus infections with influenza virus vaccine. Ann Allergy. 1979, 42: 295-305.","journal-title":"Ann Allergy"},{"key":"1773_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.virol.2006.04.015","volume":"354","author":"S Saha","year":"2006","unstructured":"Saha S, Yoshida S, Ohba K, Matsui K, Matsuda T, Takeshita F, Umeda K, Tamura Y, Okuda K, Klinman D, Xin KQ, Okuda K: A fused gene of nucleoprotein (NP) and herpes simplex virus genes(VP22) induces highly protective immunity against different subtypes of influenza virus. Virology. 2006, 354: 48-57. 10.1016\/j.virol.2006.04.015.","journal-title":"Virology"},{"key":"1773_CR66","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010, 69: 964-975. 10.1136\/ard.2009.126532.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR67","first-page":"CD006356","volume-title":"Cochrane Database Syst Rev","author":"JR Kirwan","year":"2007","unstructured":"Kirwan JR, Bijlsma JW, Boers M, Shea BJ: Effect of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev. 2007, CD006356-"},{"key":"1773_CR68","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/08830185.2010.483028","volume":"29","author":"S Salemi","year":"2010","unstructured":"Salemi S, D\u2019Amelio R: Are anti-infectious vaccinations safe and effective in patients with autoimmunity?. Int Rev Immunol. 2010, 29: 270-314. 10.3109\/08830185.2010.483028.","journal-title":"Int Rev Immunol"},{"key":"1773_CR69","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2010.137216","volume":"70","author":"S Van Assen","year":"2011","unstructured":"Van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, M\u00fcller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M: EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011, 70: 414-422. 10.1136\/ard.2010.137216.","journal-title":"Ann Rheum Dis"},{"key":"1773_CR70","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O\u2019Dell J, Winthrop KL, Beukelman T, Bridges SL, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG: 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2012, 64: 475-487. 10.1002\/acr.21591.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-12-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:24:04Z","timestamp":1630553044000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-12-77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,22]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1773"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-12-77","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,22]]},"assertion":[{"value":"19 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"77"}}